CSL Ltd. (CSLLY)
31.00
-0.36
(-1.15%)
USD |
OTCM |
Aug 26, 16:00
CSL Market Cap : 59.39B for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 59.39B |
| August 25, 2026 | 60.07B |
| August 24, 2026 | 57.66B |
| August 21, 2026 | 57.97B |
| August 20, 2026 | 58.31B |
| August 19, 2026 | 57.07B |
| August 18, 2026 | 53.83B |
| August 17, 2026 | 45.88B |
| August 14, 2026 | 46.19B |
| August 13, 2026 | 46.38B |
| August 12, 2026 | 47.21B |
| August 11, 2026 | 47.08B |
| August 10, 2026 | 45.84B |
| August 07, 2026 | 45.35B |
| August 06, 2026 | 44.93B |
| August 05, 2026 | 44.38B |
| August 04, 2026 | 44.28B |
| August 03, 2026 | 42.00B |
| July 31, 2026 | 41.73B |
| July 30, 2026 | 43.80B |
| July 29, 2026 | 42.79B |
| July 28, 2026 | 40.65B |
| July 27, 2026 | 39.23B |
| July 24, 2026 | 38.57B |
| July 23, 2026 | 38.88B |
| Date | Value |
|---|---|
| July 22, 2026 | 40.11B |
| July 21, 2026 | 41.17B |
| July 20, 2026 | 41.58B |
| July 17, 2026 | 41.96B |
| July 16, 2026 | 41.33B |
| July 15, 2026 | 41.41B |
| July 14, 2026 | 41.62B |
| July 13, 2026 | 40.69B |
| July 10, 2026 | 41.68B |
| July 09, 2026 | 42.33B |
| July 08, 2026 | 41.68B |
| July 07, 2026 | 41.81B |
| July 06, 2026 | 42.02B |
| July 02, 2026 | 39.51B |
| July 01, 2026 | 39.53B |
| June 30, 2026 | 38.69B |
| June 29, 2026 | 38.80B |
| June 26, 2026 | 38.53B |
| June 25, 2026 | 39.44B |
| June 24, 2026 | 38.40B |
| June 23, 2026 | 37.78B |
| June 22, 2026 | 38.34B |
| June 18, 2026 | 36.64B |
| June 17, 2026 | 35.50B |
| June 16, 2026 | 36.24B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immutep Ltd. | 56.00M |
| Ceryvyn Therapeutics Ltd. | 3.967M |
| Propanc Biopharma, Inc. | 0.9356M |
| Mesoblast Ltd. | 2.170B |
| Actinogen Medical Ltd. | 101.18M |
Market Cap Related Metrics
| PS Ratio | 3.802 |
| Price to Free Cash Flow | 26.68 |
| Price | 31.00 |
| Earnings Yield | -4.37% |
| Operating PE Ratio | 14.93 |
| Normalized PE Ratio | 20.86 |